Chinese medical drugs for coronavirus disease 2019: A systematic review and meta-analysis.

ABSTRACT:

Background

Integration of Chinese medical drugs (CMD) and western medicine (WM) has been widely used in the treatment of Coronavirus Disease 2019 (COVID-19). This systematic review aimed to evaluate the efficacy and safety of CMD for COVID-19.

Method

A literature search was performed in six databases from injection to June 2020. Both randomized controlled trials (RCTs) and quasi-RCTs were considered as eligible. The quality of included RCTs were assessed by Cochrane Risk of Bias Tool, and Review Manager 5.3 software was used to do meta-analysis.

Result

Eleven studies with 1259 patients were included in this study. CMD included herbal decoction and Chinese patent medicine. The methodological quality was evaluated as generally unclear. The results of meta-analysis showe

SUBMITTER: Pang W 

PROVIDER: S-EPMC7385501 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature